Structure Therapeutics Long Term Debt

Structure Therapeutics (GPCR) currently reports a long-term debt of $3.6M as of June 2026. That compares with $10M in the prior-year period — down 63.8% year over year. Use the charts on this page to explore Structure Therapeutics's long-term debt history and peer comparisons.

Structure Therapeutics's long-term debt decreased from $10M to $3.6M — a 63.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Structure Therapeutics reported $3.6M in long-term debt as of June 2026. That compares with $10M in the prior-year period — down 63.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $3.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Structure Therapeutics, and consider following GPCR for alerts when major investors trade the stock.